Zhitong Financial APP News, Shenlian Biological (688098.SH) issued an announcement that on July 6, 2023, the company received "explanation on the change of shareholders' Rights and interests and apology" and "simplified Rights and interests change report" issued by its shareholder Shanghai Hongchao Industrial Investment Co., Ltd. (hereinafter referred to as "Shanghai Hongchao") and its concerted actor Shanghai Fenghong Technology Development Partnership (Limited Partnership) (hereinafter referred to as "Shanghai Fenghong"). As of July 5, 2023, Shanghai Hongchao and its concerted actor Shanghai Fenghong reduced a total of 4.2558 million shares (with a change ratio of 1.04%) due to centralized bidding and block trading. The shareholding proportion of Shanghai Hongchao and its concerted actors Shanghai Fenghong decreased from 5.19% to 4.15%, and the proportion of equity changes exceeded 1%.
Because the above-mentioned shareholders did not find that the total shareholding ratio had dropped to less than 5% in time after the reduction of their holdings, they failed to stop the transaction in time to fulfill the information disclosure obligation of changes in rights and interests. As of the date of disclosure of this announcement, the share reduction plan disclosed by the above shareholders on April 28, 2023 has not yet been completed and is still in the reduction period.